Resolves Yes if the sponsor announces that the NTLA-2001 phase 3 trial has met its primary endpoint, as confirmed by a press release or updated ClinicalTrials.gov record.
Resolves Yes if Resolves Yes if the sponsor announces that the NTLA-2001 phase 3 trial has met its primary endpoint, as confirmed by a press release or updated ClinicalTrials.gov record.
Outcome verified from clinicaltrials.gov.
Trading on material non-public information is prohibited. Markets are for entertainment and informational purposes using free Pulse Credits — no real-money wagering. If you believe a participant has acted on inside information, please report it.
Analyzing this market…